Glucagon Suppression by Hyperglycemia in the Presence and Absence of Amino Acid Infusion

Description

This study is being done to better understand how amino acids alter the release of glucagon and insulin compared to glucose alone in health and disease.

Conditions

Healthy, Type 2 Diabetes, Obesity

Study Overview

Study Details

Study overview

This study is being done to better understand how amino acids alter the release of glucagon and insulin compared to glucose alone in health and disease.

Glucagon Suppression by Hyperglycemia in the Presence and Absence of Amino Acid Infusion

Glucagon Suppression by Hyperglycemia in the Presence and Absence of Amino Acid Infusion

Condition
Healthy
Intervention / Treatment

-

Contacts and Locations

Rochester

Mayo Clinic Rochester, Rochester, Minnesota, United States, 55905

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

    Ages Eligible for Study

    25 Years to 65 Years

    Sexes Eligible for Study

    ALL

    Accepts Healthy Volunteers

    Yes

    Collaborators and Investigators

    Mayo Clinic,

    Adrian Vella, MD, PRINCIPAL_INVESTIGATOR, Mayo Clinic

    Study Record Dates

    2025-12-31